Related posts
Markets Up on the dayMost Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)Top Biotech and Pharma Stocks to Bet on Cancer Cure & ControlThey have a new President and CEO. They released a new web site. They replace needles for dental work with laser. On the innovative side, their Durham product gives totally secure examination of a mole with results in 72 hours. The long awaited approval of the devices in Mexico is expected soon. There are expected global partnerships. He thinks there are really good opportunities for them.
This company's product is truly revolutionary, because it looks millimetres below the skin’s surface to actually see what is going on. They take a picture, send it on a secure basis to a dermatologist, who then sees the situation. A year ago, they retooled their laser therapy device, and that is selling quite well. They are working on some improved software to make it easier on a "plug-and-play" basis for the actual melanoma detection device. A great product. The company needs sales of about $1.8 million to break even, and they have $9 million of tax loss carry forward. His expectation is that by Q3 of 2018, they will be profitable. He owns warrants on this.
Medx Health Corp. is a Canadian stock, trading under the symbol MDX-X on the TSX Venture Exchange (MDX-CV). It is usually referred to as TSXV:MDX or MDX-X
In the last year, there was no coverage of Medx Health Corp. published on Stockchase.
Medx Health Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medx Health Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Medx Health Corp. In the last year. It is a trending stock that is worth watching.
On 2025-04-01, Medx Health Corp. (MDX-X) stock closed at a price of $0.06.